Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Continuous mass photometry by single-molecule trapping

An interesting methodological advance which allows hour-long mass photometry measurement of protein interactions. Previously, these types of experiments could only measure protein interactions for a few seconds.


Continuous mass photometry enables high-resolution observation of biomolecular masses and mass changes.

US firms seek new speed corridor for hypersonic flight tests

A group of US companies are looking to establish a new 250-mile speed corridor between Texas and New Mexico as a supersonic and hypersonic flight test facility.

On November 18, 2026, the four members, which includes two FAA-licensed spaceports, signed a letter of intent (LOI) to “jointly define, advocate for, and develop a dedicated high-speed flight test corridor”

Midland Development Corporation, Midland International Air & Space Port, the New Mexico Spaceport Authority, operator of Spaceport America, and Starfighters Space said the “proposal comes as federal regulators consider easing overland supersonic flight restrictions and expanding US space launch capacity”

Frequent night shifts linked to changes in heart structure and function

Frequent night-shift work is associated with differences in the structure of the heart and how the heart muscle functions, according to a new study published today in the European Heart Journal – Cardiovascular Imaging.

The team also found differences in biomarkers linked to cardiovascular health. The research is the first large-scale study to combine detailed cardiac MRI with proteomic and metabolomic profiling in relation to night-shift work.

An estimated one in five workers worldwide conduct regular night-shift work and previous research has shown it is associated with an increased risk of cardiovascular disease and cardiovascular mortality.

NASA Science Data Powers New Method to Discover Hard-to-Find Pulsars

An international team of scientists has developed a method that can find pulsars in publicly available NASA data about a million times faster than before. This opens the door to discovering many more of these rapidly spinning objects. A paper describing the results published Thursday in the Physical Review Letters.

Using 15 years of data from NASA’s Fermi Gamma-ray Space Telescope and a cryptography-based method developed by study co-authors Dotan Gazith and Barak Zackay from the Weizmann Institute of Science in Israel, the team found PSR J1622−7204, an isolated pulsar spinning 261 times per second, using the equivalent of 10 hours of computing time on a standard computer processor.

By comparison, the previous best method failed to find the pulsar, despite using enough computing power that a standard processor would take 600 years to perform the calculation.

I Think Only a Mythical Demon Could Perfectly Predict You

Astrophysicist Matt O’Dowd, host of PBS Space Time, argues that free will is real in a meaningful sense. In his view, the no-cloning theorem stops any possible observer from perfectly predicting your choices, and only Laplace’s demon, a mythical being, could. #FreeWill #Physics #Quantum Full Podcast with Matt O’Dowd: https://youtu.be/T6xLFRHW-IY …

Abstract: See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer

See the related article at Neutrophil-progenitor feedback sustains splenic myelopoiesis and promotes immune evasion in cancer.

Address for correspondence. Hongpeng Jia, Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, 1721 E. Madison Street, Baltimore, Maryland, 21,208, USA. Email: [email protected].

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and allowing those genes to switch back on.

Understanding how azacitidine works matters because the drug helps only a third to half of patients, and doctors have no reliable way to predict who will benefit.

In a recent study published in Molecular Cell, researchers at the University of Chicago and UT Health San Antonio report that during the first day of treatment, when the drug kills the most cancer cells, almost none of it happens in DNA, but instead mostly in RNA. There, it strips chemical tags from RNA and shuts down genes that cancer cells need to divide and repair their DNA. The research findings point to NSUN2, the enzyme that installs those tags, as a more precise drug target.